Skip to content

Heart rate control for patients with atrial fibrillation and hypertension:Efficacy and safety of carvedilol

Heart rate control for patients with atrial fibrillation and hypertension:Efficacy and safety of carvedilol - Heart rate control for patients with atrial fibrillation and hypertension:Efficacy and safety of carvedilol

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004949
Enrollment
40
Registered
2011-02-01
Start date
2011-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Sponsors

Division of Cardiology,Department of Internal Medicine,Kinki University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: permanent atrial fibrillation hypertension either out or in hospital follow up

Exclusion criteria

Exclusion criteria: heart failure,severe cardiac dysfunction high degree atrio-ventricular block,sick sinus syndrome,bradycardia bronchial asthma diabetic ketoacidosis,metabolic acidosis acute myocardial infarction dialysis patient,severe renal dysfunction pregnant woman,woman with chance of pregnancy untreated pheochromocytoma hypersensitivity to the medicine a case determined inappropriate

Design outcomes

Primary

MeasureTime frame
improvement of QOL

Secondary

MeasureTime frame
rate control cardiovascular event cardiac function inflammatory markers oxidative stress markers

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026